Peikun He

478 total citations
23 papers, 327 citations indexed

About

Peikun He is a scholar working on Molecular Biology, Neurology and Epidemiology. According to data from OpenAlex, Peikun He has authored 23 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Neurology and 6 papers in Epidemiology. Recurrent topics in Peikun He's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (5 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Peikun He is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (5 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Peikun He collaborates with scholars based in China and Hong Kong. Peikun He's co-authors include Yuling Xu, Yuhua Jia, Xiaoyu Liu, Mukeng Hong, Yuyuan Gao, Kun Nie, Yuhu Zhang, Lanlan Hu, Guixian Ma and Lijuan Wang and has published in prestigious journals such as Annals of Neurology, Free Radical Biology and Medicine and Neuroscience.

In The Last Decade

Peikun He

18 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peikun He China 11 111 73 56 55 52 23 327
Hechen Zhu China 10 114 1.0× 23 0.3× 49 0.9× 41 0.7× 40 0.8× 18 340
Yajun He China 12 99 0.9× 22 0.3× 69 1.2× 58 1.1× 28 0.5× 22 351
Özden Kamışlı Türkiye 10 74 0.7× 46 0.6× 28 0.5× 45 0.8× 21 0.4× 32 324
Jingyi Xu China 9 143 1.3× 22 0.3× 82 1.5× 27 0.5× 16 0.3× 24 329
Xin Mou China 10 134 1.2× 47 0.6× 16 0.3× 50 0.9× 24 0.5× 28 377
Cheng Gu China 10 75 0.7× 85 1.2× 43 0.8× 16 0.3× 7 0.1× 29 423
Vibha Shukla India 9 79 0.7× 25 0.3× 27 0.5× 75 1.4× 16 0.3× 22 299
Yu Shangguan United States 12 146 1.3× 28 0.4× 27 0.5× 60 1.1× 56 1.1× 19 394
Junyi Sun China 11 118 1.1× 18 0.2× 36 0.6× 29 0.5× 17 0.3× 28 313

Countries citing papers authored by Peikun He

Since Specialization
Citations

This map shows the geographic impact of Peikun He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peikun He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peikun He more than expected).

Fields of papers citing papers by Peikun He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peikun He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peikun He. The network helps show where Peikun He may publish in the future.

Co-authorship network of co-authors of Peikun He

This figure shows the co-authorship network connecting the top 25 collaborators of Peikun He. A scholar is included among the top collaborators of Peikun He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peikun He. Peikun He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Peikun, et al.. (2025). Do Novel Nonexercise and Nondrug Treatments Improve Global Cognition in Parkinson's Disease Patients? A Systematic Review and Bayesian Analysis. European Journal of Neuroscience. 61(3). e70008–e70008. 2 indexed citations
2.
Yao, Jin, Yaxin Zhang, Lifang Zhang, et al.. (2025). Aurantio‐Obtusin Regulates Gut Microbiota and Serum Metabolism to Alleviate High‐Fat Diet‐Induced Obesity‐Associated Non‐Alcoholic Fatty Liver Disease in Mice. Phytotherapy Research. 39(5). 1946–1965. 3 indexed citations
3.
Cheng, Xiaomin, Shuo Shi, Di Cao, et al.. (2025). Cavidine alleviates paclitaxel-induced peripheral neuropathy by promoting mitochondrial autophagy through inhibiting PKM2-mediated histone lactylation. Free Radical Biology and Medicine. 241. 367–383.
4.
Liu, Xiaoyu, Jin Yao, Zhaoyong Li, et al.. (2025). Dingxin recipe III ameliorates endothelial cell senescence in atherosclerosis by activating the FOXO3a/PINK1/Parkin axis. Journal of Ethnopharmacology. 354. 120525–120525.
5.
He, Peikun, Rong Z. Gan, Jieling Chen, et al.. (2024). Differential diagnosis value of sympathetic skin response and cutaneous silent period on early-stage multiple system atrophy and Parkinson disease. Parkinsonism & Related Disorders. 126. 107046–107046. 2 indexed citations
6.
Zhang, Qingxi, Shibo Jiang, Kun Nie, et al.. (2024). Transmission of peripheral blood α-synuclein fibrils exacerbates synucleinopathy and neurodegeneration in Parkinson’s disease by endothelial Lag3 endocytosis. American Journal of Physiology-Cell Physiology. 328(3). C836–C855.
7.
Zhang, Yaxin, Lifang Zhang, Zhaoyong Li, et al.. (2024). Gualou-Xiebai-Banxia-Tang regulates liver-gut axis to ameliorate Metabolic Syndrome in HFD-fed mice. Phytomedicine. 132. 155320–155320. 5 indexed citations
8.
Mao, Ting, et al.. (2024). Impacts of small-molecule STAT3 inhibitor SC-43 on toxicity, global proteomics and metabolomics of HepG2 cells. Journal of Pharmaceutical and Biomedical Analysis. 242. 116023–116023.
9.
He, Peikun, Yuyuan Gao, Lin Shi, et al.. (2023). Motor progression phenotypes in early-stage Parkinson’s Disease: A clinical prediction model and the role of glymphatic system imaging biomarkers. Neuroscience Letters. 814. 137435–137435. 6 indexed citations
10.
He, Peikun, Shujun Feng, Yuyuan Gao, et al.. (2023). Neuronavigated repetitive transcranial magnetic stimulation improves depression, anxiety and motor symptoms in Parkinson’s disease. Heliyon. 9(8). e18364–e18364. 4 indexed citations
11.
He, Peikun, Lin Shi, Yanyi Li, et al.. (2023). The Association of the Glymphatic Function with Parkinson's Disease Symptoms: Neuroimaging Evidence from Longitudinal and Cross‐Sectional Studies. Annals of Neurology. 94(4). 672–683. 41 indexed citations
12.
Zhang, Qingxi, Kun Nie, J. Joshua Yang, et al.. (2023). Myo1d promotes alpha-synuclein transfer from brain microvascular endothelial cells to pericytes through tunneling nanotubes. iScience. 26(8). 107458–107458. 12 indexed citations
13.
He, Peikun, Yuyuan Gao, Lin Shi, et al.. (2023). The association of CSF biomarkers and cognitive decline with choroid plexus volume in early Parkinson's disease. Parkinsonism & Related Disorders. 120. 105987–105987. 6 indexed citations
14.
He, Peikun, Hao Wang, Lifang Zhang, et al.. (2023). Geniposide ameliorates atherosclerosis by regulating macrophage polarization via perivascular adipocyte-derived CXCL14. Journal of Ethnopharmacology. 314. 116532–116532. 14 indexed citations
15.
Gao, Yuyuan, Qingxi Zhang, Peikun He, et al.. (2022). Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson’s Disease. Molecular Neurobiology. 60(2). 979–1003. 14 indexed citations
16.
Gao, Yuyuan, Jianing Chen, Peikun He, et al.. (2022). TGR5 Agonist INT-777 Alleviates Inflammatory Neurodegeneration in Parkinson’s Disease Mouse Model by Modulating Mitochondrial Dynamics in Microglia. Neuroscience. 490. 100–119. 28 indexed citations
17.
Liu, Xiaoyu, Yuling Xu, Xinghong Zhou, et al.. (2021). Geniposide Combined With Notoginsenoside R1 Attenuates Inflammation and Apoptosis in Atherosclerosis via the AMPK/mTOR/Nrf2 Signaling Pathway. Frontiers in Pharmacology. 12. 687394–687394. 50 indexed citations
18.
Chen, Jianing, Peikun He, Yuhu Zhang, et al.. (2020). Non-pharmacological treatment for Parkinson disease patients with depression: a meta-analysis of repetitive transcranial magnetic stimulation and cognitive-behavioral treatment. International Journal of Neuroscience. 131(4). 411–424. 17 indexed citations
19.
Hong, Mukeng, Lanlan Hu, Yuling Xu, et al.. (2020). 6-Gingerol ameliorates sepsis-induced liver injury through the Nrf2 pathway. International Immunopharmacology. 80. 106196–106196. 68 indexed citations
20.
He, Peikun, et al.. (2019). Spinosin and 6'''‑Feruloylspinosin protect the heart against acute myocardial ischemia and reperfusion in rats. Molecular Medicine Reports. 20(5). 4253–4261. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hechen Zhu Breakdown of academic impact, for papers by Yajun He Breakdown of academic impact, for papers by Özden Kamışlı Breakdown of academic impact, for papers by Jingyi Xu Breakdown of academic impact, for papers by Xin Mou Breakdown of academic impact, for papers by Cheng Gu Breakdown of academic impact, for papers by Vibha Shukla Breakdown of academic impact, for papers by Yu Shangguan Breakdown of academic impact, for papers by Junyi Sun
Rankless by CCL
2026